Vaso Corporation (VASO)

[ProfitScout]

Vasomedical to Report Third Quarter 2013 Results on November 14, 2013

Management to hold investor conference call on November 14th at 1:00 p.m. ET

WESTBURY, N.Y., Nov. 5, 2013 /PRNewswire via COMTEX/ -- Vasomedical, Inc. (OTC BB: VASO), announced today that it will release its financial results for the three months ended September 30, 2013 on Thursday, November 14, 2013.

The Company will host a conference call on Thursday, November 14th at 1:00 p.m. ET featuring remarks by Jun Ma, Ph.D., President and CEO of Vasomedical, and Michael Beecher, Chief Financial Officer of Vasomedical. To dial into the conference call, please dial 1-866-393-1344 from the U.S. or 1-631-291-4669, internationally. All dial-in participants must use the following code to access the call: 94523097. Please call at least five minutes before the scheduled start time. The conference call will also be available via webcast and can be accessed through the Investor Relations section of Vasomedical's website, http://www.vasomedical.com, and http://www.kcsa.com. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.

A replay of the conference call will be available approximately two hours after completion of the live conference call at http://www.vasomedical.com or http://www.kcsa.com. To access the dial-in replay of the call, which will be available until December 16, 2013, please dial 1-855-859-2056 or 1-404-537-3406. All dial-in participants must use the following code to access the call: 94523097.

About Vasomedical

Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products. The Company's main proprietary products are EECP Therapy systems, the gold standard of ECP treatment. The Company operates through three wholly owned subsidiaries: VasoSolutions, Vasomedical Global and VasoHealthcare. VasoSolutions manages and coordinates the design, manufacture and sales of EECP Therapy systems, and other medical equipment operations; Vasomedical Global operates the Company's China-based subsidiaries; and VasoHealthcare is the operating subsidiary for the exclusive sales representation of GE Healthcare diagnostic imaging products in certain market segments. Additional information is available on the Company's website at http://www.vasomedical.com.

Investor Contacts:
Todd Fromer / Garth Russell KCSA Strategic Communications 212-896-1215 / 212-896-1250 [e-mail] / [e-mail]

SOURCE Vasomedical, Inc.

http://rt.prnewswire.com/rt.gif?NewsItemId=NY09909&Transmission_Id=201311050800PR_NEWS_USPR_____NY09909&DateId=20131105

www.prnewswire.com
Copyright (C) 2013 PR Newswire. All rights reserved